Premenstrual Syndrome Treatment Market By Treatment 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Premenstrual Syndrome Treatment Market
Premenstrual Syndrome Treatment Market: By Treatment (Painkillers, Oral Contraceptive Pills, Estrogen-Only Patches & Implants, Gonadotropin-Releasing Hormone (GnRH) Analogues, Selective Serotonin Reuptake Inhibitors (SSRIs)) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0267
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Premenstrual Syndrome Treatment Market –Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Premenstrual Syndrome Treatment Market– Forces
   4.1. Drivers
      4.1.1. Growing registered cases of PMS due to changing life style
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Premenstrual Syndrome Treatment Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. Premenstrual Syndrome Treatment Market, By Treatment
   6.1. Painkillers
   6.2. Oral contraceptive pills
   6.3. Estrogen-only patches & implants
   6.4. Gonadotropin-releasing hormone (GnRH) analogues
   6.5. Selective serotonin reuptake inhibitors (SSRIs)
7. Premenstrual Syndrome Treatment Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Premenstrual Syndrome Treatment – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Pherin Pharmaceuticals, Inc.
   9.2. DEKK-TEC, Inc.
   9.3. Umecrine Mood AB
   9.4. MetP Pharma AG
   9.5. Bristol Meyer Squibb
   9.6. Merck and Co.
   9.7. Novartis AG
   9.8. Pfizer, Inc.
   9.9. Cipla Laboratories.
   9.10. Dr. Reddy’s Laboratories Ltd
* More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibiliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Premenstrual syndrome (PMS) is medical condition involving emotional, physical, psychological, and mood disturbances that occur after a woman's ovulation, and typically ends with the onset of her menstrual flow. The most common mood-related symptoms involved in premenstrual syndrome are irritability, depression, crying, oversensitivity, and mood swings. The most common physical symptoms involved in premenstrual syndrome are fatigue, bloating, breast tenderness (mastalgia), acne, and appetite changes with food cravings. One of the advanced and more severe form of PMS is premenstrual dysphoric disorder (PMDD) also known as late luteal phase dysphoric disorder, occurs in a smaller number of women and leads to significant loss of function because of unusually severe symptoms. Globally increasing registered cases of PMS due to life style related issues and increasing awareness amongst women in the developed nations is expected to drive the demand for PMS however regulations over the usage of such medicines in some of the nations and higher R&D cost involved to develop new drugs and treatments is expected to be the key constraints market during the period of study.

This report identifies the global premenstrual syndrome treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to premenstrual syndrome treatment market.
 
Premenstrual Syndrome Treatment Market

Geographically, North America dominated the premenstrual syndrome treatment market due to higher awareness about such diseases, higher registered cases due to life style related health issues and well developed healthcare infrastructure. North America was followed by Europe and Asia-Pacific as the second and third largest consumer of premenstrual syndrome treatment. Asia Pacific is projected to have the fastest growth, owing to rapidly expanding healthcare infrastructure, increasing awareness especially in the major regional economies such as India and China in the region.

This report segments premenstrual syndrome treatment market on the basis of treatment type and regional market as follows:

  • On the basis of treatment type this report on premenstrual syndrome treatment market is segmented as follows, covering major segments as follows: Painkillers, Oral contraceptive pills, Estrogen-only patches and implants, Gonadotropin-releasing hormone (GnRH) analogues, Selective serotonin reuptake inhibitors (SSRIs)
  • This report on premenstrual syndrome treatment has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the premenstrual syndrome treatment market. Some of the major companies’ profiles in detail are as follows:
  • Pherin Pharmaceuticals, Inc.
  • DEKK-TEC, Inc.
  • Umecrine Mood AB
  • MetP Pharma AG
  • Bristol Meyer Squibb
List of Tables:

Table 1: Premenstrual Syndrome Treatment Market Overview 2017-2023
Table 2: Premenstrual Syndrome Treatment Market Leader Analysis 2017-2018 (US$)
Table 3: Premenstrual Syndrome Treatment Market Product Analysis 2017-2018 (US$)
Table 4: Premenstrual Syndrome Treatment Market End User Analysis 2017-2018 (US$)
Table 5: Premenstrual Syndrome Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Premenstrual Syndrome Treatment Market Financial Analysis 2017-2018 (US$)
Table 7: Premenstrual Syndrome Treatment Market Driver Analysis 2017-2018 (US$)
Table 8: Premenstrual Syndrome Treatment Market Challenges Analysis 2017-2018 (US$)
Table 9: Premenstrual Syndrome Treatment Market Constraint Analysis 2017-2018 (US$)
Table 10: Premenstrual Syndrome Treatment Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Premenstrual Syndrome Treatment Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Premenstrual Syndrome Treatment Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Premenstrual Syndrome Treatment Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Premenstrual Syndrome Treatment Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Premenstrual Syndrome Treatment Market Value Chain Analysis 2017-2018 (US$)
Table 16: Premenstrual Syndrome Treatment Market Pricing Analysis 2018-2023 (US$)
Table 17: Premenstrual Syndrome Treatment Market Opportunities Analysis 2018-2023 (US$)
Table 18: Premenstrual Syndrome Treatment Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Premenstrual Syndrome Treatment Market Supplier Analysis 2017-2018 (US$)
Table 20: Premenstrual Syndrome Treatment Market Distributor Analysis 2017-2018 (US$)
Table 21: Premenstrual Syndrome Treatment Market Trend Analysis 2017-2018 (US$)
Table 22: Premenstrual Syndrome Treatment Market Size 2017 (US$)
Table 23: Premenstrual Syndrome Treatment Market Forecast Analysis 2018-2023 (US$)
Table 24: Premenstrual Syndrome Treatment Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 26: Premenstrual Syndrome Treatment Market By Treatment, Revenue & Volume, By Painkillers, 2018-2023 ($)
Table 27: Premenstrual Syndrome Treatment Market By Treatment, Revenue & Volume, By Oral contraceptive pills, 2018-2023 ($)
Table 28: Premenstrual Syndrome Treatment Market By Treatment, Revenue & Volume, By Estrogen-only patches & implants, 2018-2023 ($)
Table 29: Premenstrual Syndrome Treatment Market By Treatment, Revenue & Volume, By Gonadotropin-releasing hormone (GnRH) analogues, 2018-2023 ($)
Table 30: Premenstrual Syndrome Treatment Market By Treatment, Revenue & Volume, By Selective serotonin reuptake inhibitors (SSRIs), 2018-2023 ($)
Table 31: North America Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 32: South america Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 33: Europe Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 34: APAC Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 35: Middle East & Africa Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 36: Russia Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 37: Israel Premenstrual Syndrome Treatment Market, Revenue & Volume, By Treatment, 2018-2023 ($)
Table 38: Top Companies 2017 (US$) Premenstrual Syndrome Treatment Market, Revenue & Volume
Table 39: Product Launch 2017-2018 Premenstrual Syndrome Treatment Market, Revenue & Volume
Table 40: Mergers & Acquistions 2017-2018 Premenstrual Syndrome Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Premenstrual Syndrome Treatment Market 2017-2023
Figure 2: Market Share Analysis for Premenstrual Syndrome Treatment Market 2017 (US$)
Figure 3: Product Comparison in Premenstrual Syndrome Treatment Market 2017-2018 (US$)
Figure 4: End User Profile for Premenstrual Syndrome Treatment Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Premenstrual Syndrome Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Premenstrual Syndrome Treatment Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Premenstrual Syndrome Treatment Market 2017-2018
Figure 8: Ecosystem Analysis in Premenstrual Syndrome Treatment Market 2017
Figure 9: Average Selling Price in Premenstrual Syndrome Treatment Market 2017-2023
Figure 10: Top Opportunites in Premenstrual Syndrome Treatment Market 2017-2018
Figure 11: Market Life Cycle Analysis in Premenstrual Syndrome Treatment Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TreatmentPremenstrual Syndrome Treatment Market Revenue, 2018-2023 ($)
Figure 13: Global Premenstrual Syndrome Treatment Market - By Geography
Figure 14: Global Premenstrual Syndrome Treatment Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global Premenstrual Syndrome Treatment Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 17: US Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP – Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada GDP – Composition of 2017, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Mexico Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 26: Mexico GDP and Population, 2017-2018 ($)
Figure 27: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29: South America Premenstrual Syndrome Treatment Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil GDP and Population, 2017-2018 ($)
Figure 32: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34: Venezuela Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 35: Venezuela GDP and Population, 2017-2018 ($)
Figure 36: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Argentina Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 39: Argentina GDP and Population, 2017-2018 ($)
Figure 40: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Ecuador Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 43: Ecuador GDP and Population, 2017-2018 ($)
Figure 44: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Peru Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 47: Peru GDP and Population, 2017-2018 ($)
Figure 48: Peru GDP – Composition of 2017, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Colombia Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 51: Colombia GDP and Population, 2017-2018 ($)
Figure 52: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Costa Rica Premenstrual Syndrome Treatment Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55: Costa Rica GDP and Population, 2017-2018 ($)
Figure 56: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Europe Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 59: U.K Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 60: U.K GDP and Population, 2017-2018 ($)
Figure 61: U.K GDP – Composition of 2017, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63: Germany Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 64: Germany GDP and Population, 2017-2018 ($)
Figure 65: Germany GDP – Composition of 2017, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Italy Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 68: Italy GDP and Population, 2017-2018 ($)
Figure 69: Italy GDP – Composition of 2017, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71: France Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 72: France GDP and Population, 2017-2018 ($)
Figure 73: France GDP – Composition of 2017, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2017-2018 ($)
Figure 75: Netherlands Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 76: Netherlands GDP and Population, 2017-2018 ($)
Figure 77: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Belgium Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 80: Belgium GDP and Population, 2017-2018 ($)
Figure 81: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Spain Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 84: Spain GDP and Population, 2017-2018 ($)
Figure 85: Spain GDP – Composition of 2017, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Denmark Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 88: Denmark GDP and Population, 2017-2018 ($)
Figure 89: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91: APAC Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 92: China Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023
Figure 93: China GDP and Population, 2017-2018 ($)
Figure 94: China GDP – Composition of 2017, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2017-2018 ($)Premenstrual Syndrome Treatment Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 96: Australia Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 97: Australia GDP and Population, 2017-2018 ($)
Figure 98: Australia GDP – Composition of 2017, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100: South Korea Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 101: South Korea GDP and Population, 2017-2018 ($)
Figure 102: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104: India Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 105: India GDP and Population, 2017-2018 ($)
Figure 106: India GDP – Composition of 2017, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2017-2018 ($)
Figure 108: Taiwan Premenstrual Syndrome Treatment Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109: Taiwan GDP and Population, 2017-2018 ($)
Figure 110: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Malaysia Premenstrual Syndrome Treatment Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Malaysia GDP and Population, 2017-2018 ($)
Figure 114: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Hong Kong Premenstrual Syndrome Treatment Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Hong Kong GDP and Population, 2017-2018 ($)
Figure 118: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Middle East & Africa Premenstrual Syndrome Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia Premenstrual Syndrome Treatment Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia GDP and Population, 2017-2018 ($)
Figure 123: Russia GDP – Composition of 2017, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125: Israel Premenstrual Syndrome Treatment Market Value & Volume, 2018-2023 ($)
Figure 126: Israel GDP and Population, 2017-2018 ($)
Figure 127: Israel GDP – Composition of 2017, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Entropy Share, By Strategies, 2017-2018* (%)Premenstrual Syndrome Treatment Market
Figure 130: Developments, 2017-2018*Premenstrual Syndrome Treatment Market
Figure 131: Company 1 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 132: Company 1 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133: Company 1 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 134: Company 2 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 2 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 2 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 3 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 3 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 3 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 4 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 4 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 4 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 5 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 5 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 5 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 6 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 6 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 6 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 7 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 7 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 7 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 8 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 8 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 8 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 9 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 9 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 9 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 10 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 10 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 10 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 11 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 11 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 11 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 12 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 12 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 12 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 13 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 13 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 13 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 14 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 14 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 14 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 15 Premenstrual Syndrome Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 15 Premenstrual Syndrome Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 15 Premenstrual Syndrome Treatment Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll